Despite the progress made during the last decades in the prevention and treatment of cardiovascular diseases, heart failure is still associated with a high ...

Shares of scPharmaceuticals have lost 37% over the past 3 years and are down 11% in 2025. Find out why SCPH stock is a Buy.

A study led by a physician-scientist at the University of Arizona College of Medicine–Tucson's Sarver Heart Center identified ...

These exploratory results from the FINEARTS-HF trial require confirmation in dedicated trials. REDEFINE-HF is underway.